Walgreen Company 8-K 2012
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 27, 2012
(Exact name of registrant as specified in its charter)
Registrant’s telephone number, including area code:(847) 315-2500
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Item 2.02 Results of Operations and Financial Condition.
On March 27, 2012, Walgreen Co. issued a press release announcing financial results for the quarter ended February 29, 2012. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated by reference herein.
This information, including exhibits attached hereto and the information under Item 7.01 below, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to this Form 8-K in such a filing.
Item 7.01 Regulation FD Disclosure.
In addition to issuing a press release, Walgreen Co. is also conducting a conference call and webcast regarding results for the quarter ended February 29, 2012. Slides prepared for the purposes of the conference call are available on the Walgreens investor relations website at http://investor.walgreens.com.
Item 9.01 Financial Statements and Exhibits.
The following exhibit is being furnished as part of this Form 8-K:
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.